Try the elleFA app to help track endometriosis symptoms and treatments.
Official title: Evaluating the Feasibility of elleFA App Implementation
Run by McGill University Health Centre/Research Institute of the McGill University Health Centre · NCT06452407 · Data updated 2026-11-12
This project will try a smartphone app called elleFA to help pre-menopausal women with known or suspected endometriosis who are receiving care at the McGill University Health Centre track symptoms and treatments more accurately.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 20 (estimated) |
| Sponsor | McGill University Health Centre/Research Institute of the McGill University Health Centre Academic / other |
| Locations | 1 site (Montreal, Quebec) |
| Status | Recruiting |
| Started | December 16, 2025 |
| Main results expected | July 2027 |
| Study ends | August 2027 |
| Registry record updated | November 3, 2026 |
| Trial ID | NCT06452407 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are pre-menopausal women aged 18 or older with known or suspected endometriosis who are undergoing medical management at the McGill University Health Centre and can consent in English or French.
✕Probably not a fit
Patients who are post-menopausal, actively pregnant, seeking pregnancy, or not receiving care at MUHC (or who do not use a smartphone) are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Participants who are 18 or older, pre-menopausal, and receiving medical management for endometriosis at MUHC will install and use the elleFA smartphone app to log symptoms, treatments, and related events over a defined period. The study will collect data on how often and how well participants use the app, barriers to use, and whether the app improves completeness of symptom and treatment records. Consent and study materials are available in English and French, and investigators will analyze usage patterns and feasibility metrics to inform wider implementation. No investigational medications or procedures are administered as part of this implementation study.
Why it matters
Potential benefit: If successful, the app could improve symptom tracking and patient–provider communication, helping patients and clinicians find better treatments faster.
How similar studies have gone: Mobile health apps for pain and menstrual tracking have shown promise for engagement and symptom logging, but apps specifically designed for endometriosis are largely novel and have limited published evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Pre-menopausal women 18 years of age or older with known or suspected endometriosis * Undergoing medical management of endometriosis at the MUHC * Able to provide informed consent in French or in English Exclusion Criteria: * Menopausal status * Pregnant or seeking pregnancy
Where it's running
-
McGill University Health Center
Montreal, Quebec, Canada Recruiting
Study contacts
- Principal investigator: Andrew Zakhari, MD — McGill University Health Centre/Research Institute of the McGill University Health Centre
- Study coordinator: Andrew Zakhari, MD
- Email: andrew.zakhari@mcgill.ca
- Phone: 514-934-1934
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comparing different techniques to treat endometriosis
This study is testing different methods to treat endometriosis, like laser and heat techniques, to see which one works best for relieving pain in women who are already having surgery for the condition.
-
Postoperative Pain Trajectories After Endometriosis Surgery
This study tests how pain changes after endometriosis surgery and whether perioperative pain testing can predict who will have ongoing pain.
-
Imaging endometriosis with a special PET tracer in adult women
This study tests whether a PET/CT scan using [18F]AlF-FAPI-74 can help detect endometriosis lesions in women who are planning laparoscopy.
-
Fiber supplement for digestive symptoms in endometriosis
A fiber-based supplement is being tested to see if it is safe and helps with gut and vaginal microbiomes and digestive symptoms in women with endometriosis.
-
Stellate ganglion block and dexmedetomidine for better sleep after gynecologic laparoscopy
The study tests whether giving a preoperative stellate ganglion block plus intraoperative dexmedetomidine improves sleep after laparoscopic gynecologic surgery in women.
-
Atypical Endometriosis: Histology, Immunophenotype and Molecular Features
Researchers will look at how endometriotic tissue that looks atypical under the microscope relates to clinical features and ultrasound findings to better separate benign from potentially atypical lesions.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.